Biblio Discovery — Demo Discovery Service

8 hasil untuk "Alexander Partin"

Menampilkan 1–8 · 0,95 detik · RSS

  1. Artikel Jurnal

    Deep learning methods for drug response prediction in cancer: Predominant and emerging trends

    Alexander Partin; Thomas S. Brettin; Yitan Zhu dkk.

    Frontiers in Medicine, Vol. 10 · 2023 · Inggris · DOAJ Scopus

    Cancer claims millions of lives yearly worldwide. While many therapies have been made available in recent years, by in large cancer remains unsolved. Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of…

  2. Artikel Jurnal

    Converting tabular data into images for deep learning with convolutional neural networks

    Yitan Zhu; Thomas Brettin; Fangfang Xia dkk.

    Scientific Reports, Vol. 11 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Convolutional neural networks (CNNs) have been successfully used in many applications where important information about data is embedded in the order of features, such as speech and imaging. However, most tabular data do not assume a spatial relationship between features, and thus are…

  3. Artikel Jurnal

    AI-accelerated protein-ligand docking for SARS-CoV-2 is 100-fold faster with no significant change in detection

    Austin Clyde; Xuefeng Liu; Thomas Brettin dkk.

    Scientific Reports, Vol. 13 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Protein-ligand docking is a computational method for identifying drug leads. The method is capable of narrowing a vast library of compounds down to a tractable size for downstream simulation or experimental testing and is widely used in drug discovery. While there has been progress in…

  4. Artikel Jurnal

    Learning curves for drug response prediction in cancer cell lines

    Alexander Partin; Thomas Brettin; Yvonne A. Evrard dkk.

    BMC Bioinformatics, Vol. 22 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Motivated by the size and availability of cell line drug sensitivity data, researchers have been developing machine learning (ML) models for predicting drug response to advance cancer treatment. As drug sensitivity studies continue generating drug response data, a common…

  5. Artikel Jurnal

    PLP1-triggered NOT gate to address neurotoxicity risk of PSMA-targeted prostate cancer therapy

    Alexander Kamb; Vasantika Suryawanshi; Chawita Netirojjanakul dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 14 No. 9 · 2026 · Inggris · DOAJ Scopus

    Background On-target, off-tumor toxicity is a recurring challenge for solid tumor therapeutics targeted to antigens preferentially expressed on malignant cells. Prostate-specific membrane antigen (PSMA) is a tumor-associated antigen that is expressed on the healthy prostate and is generally…

  6. Artikel Jurnal

    Onboard, tethered IL-12 boosts potency of the Tmod NOT gate and preserves selectivity

    Alexander Kamb; Sara Imboden; Dongwoo Lee dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 13 No. 5 · 2025 · Inggris · DOAJ Scopus

    Background To reach their full potential in cancer therapy, immune cells engineered with synthetic constructs must achieve the challenging dual objectives of potency and selectivity to overcome the key obstacle: non-specific cytotoxicity. These problems are especially challenging for solid tumor…

  7. Artikel Jurnal

    Data augmentation and multimodal learning for predicting drug response in patient-derived xenografts from gene expressions and histology images

    Alexander Partin; Thomas Brettin; Yitan Zhu dkk.

    Frontiers in Medicine, Vol. 10 · 2023 · Inggris · DOAJ Scopus

    Patient-derived xenografts (PDXs) are an appealing platform for preclinical drug studies. A primary challenge in modeling drug response prediction (DRP) with PDXs and neural networks (NNs) is the limited number of drug response samples. We investigate multimodal neural network (MM-Net) and data…